bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding bluebird bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 152 | 1 | 140 | −11 |
| Shares | 78.5M | 15.4M | 62.7M | −359.8K (−0.6%) |
| Value | $77.2M | $15.2M | $32.9M | −$29.1M (−47.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held bluebird bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 15,443,767 | $8.02M | 0.00% |
| Avidity Partners Management LP | 1,631,143 | $847.4K | 0.04% |
| ExodusPoint Capital Management, LP | 1,296,668 | $674.0K | 0.01% |
| Marshall Wace, LLP | 308,656 | $160.5K | 0.00% |
| Verition Fund Management LLC | 81,127 | $42.1K | 0.00% |
| Engineers Gate Manager LP | 53,772 | $27.9K | 0.00% |
| Avantax Planning Partners, Inc. | 50,000 | $26.0K | 0.00% |
| Creative Planning | 23,350 | $12.1K | 0.00% |
| Wolverine Trading, LLC | 17,901 | $9.03K | 0.00% |
| Abel Hall, LLC | 15,432 | $8.02K | 0.01% |
| Semus Wealth Partners LLC | 10,200 | $5.30K | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,868 | $1.49K | 0.00% |
| Capital Advisors, Ltd. LLC | 1,166 | $1.00K | 0.00% |
| Sterling Capital Management LLC | 608 | $316 | 0.00% |
| Capital Performance Advisors LLP | 173 | $90 | 0.00% |
| Truvestments Capital LLC | 125 | $65 | 0.00% |
| National Bank of Canada | 81 | $42 | 0.00% |
Sold out (28)
Institutions that held bluebird bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (1)
Institutions that held bluebird bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 15,442,212 | $15.2M |